zami 1327 has been researched along with alprenolol in 1 studies
| Studies (zami 1327) | Trials (zami 1327) | Recent Studies (post-2010) (zami 1327) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 1,146 | 121 | 59 |
| Protein | Taxonomy | zami 1327 (IC50) | alprenolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
| Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishbein, L; Jackson, CD | 1 |
1 review(s) available for zami 1327 and alprenolol
| Article | Year |
|---|---|
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |